⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
RDY News
Dr. Reddy's Laboratories Limited American Depositary Shares
DR. REDDY’S LABORATORIES INVESTOR ALERT: Kirby McInerney LLP Announces Investigation Into Potential Securities Fraud
globenewswire.com
RDY
Bronstein, Gewirtz & Grossman, LLC Encourages Dr. Reddy's Laboratories Limited (RDY) Stockholders to Inquire about Securities Investigation
accessnewswire.com
RDY
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Dr. Reddy's Laboratories Limited (RDY) and Encourages Investors to Learn More About the Investigation
accessnewswire.com
RDY
Dr. Reddy’s Announces the First-to-Market Launch of Sugammadex Injection 200 mg/2 mL (100 mg/mL) and 500 mg/5 mL (100 mg/mL) Single-Dose Vials, a Generic Equivalent of Bridion ®, in the United States
businesswire.com
RDY
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Dr. Reddy's Laboratories Limited (RDY) and Encourages Stockholders to Learn More About the Investigation
accessnewswire.com
RDY
Bronstein, Gewirtz & Grossman, LLC Encourages Dr. Reddy's Laboratories Limited (RDY) Investors to Inquire about Securities Investigation
accessnewswire.com
RDY
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Dr. Reddy's Laboratories Limited (RDY) And Encourages Investors to Reach Out
accessnewswire.com
RDY
Dr. Reddy's Laboratories (RDY) Securities Investigation Notice - Levi & Korsinsky
prnewswire.com
RDY
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Dr. Reddy's Laboratories Limited (RDY) And Encourages Stockholders to Reach Out
accessnewswire.com
RDY
RDY Investor Alert: Levi & Korsinsky Investigates Dr. Reddy's Laboratories Limited (RDY) For Potential Securities Fraud
accessnewswire.com
RDY